Andrew Nixon - Dissemin

All papers authored by Andrew Nixon

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2024 Akram Yazdani, Azam Yazdani, Raul Mendez-Giraldez, Gianluigi Pillonetto, Esmat Samiei, Reza Hadi, Heinz-Josef Lenz, Alan Venook, Ahmad Samiei, Andrew Nixon

, Scott Kopetz, Monica Bertagnolli, Charles Perou, Federico Innocenti

Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies

Upload

Ghassan K. Abou Alfa, Susan M. Geyer, Andrew B. Nixon

, Federico Innocenti, Qian Shi, Priya Kumthekar, Sawyer Jacobson

, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H. Schwartz, Anthony B. El Khoueiry and 6 other authors

Supplementary Figure 4 from CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Upload

Ghassan K. Abou Alfa, Susan M. Geyer, Andrew B. Nixon

, Federico Innocenti, Qian Shi, Priya Kumthekar, Sawyer Jacobson

, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H. Schwartz, Anthony B. El Khoueiry and 6 other authors

Data from CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Upload

Ghassan K. Abou Alfa, Susan M. Geyer, Andrew B. Nixon

, Federico Innocenti, Qian Shi, Priya Kumthekar, Sawyer Jacobson

, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H. Schwartz, Anthony B. El Khoueiry and 6 other authors

FIGURE 3 from CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Upload

This paper was not found in any repository, but could be made available legally by the author.

Ghassan K. Abou-Alfa

, Susan M. Geyer

, Andrew B. Nixon

, Federico Innocenti

, Qian Shi

, Priya Kumthekar

, Sawyer Jacobson

, Imane El Dika

, Amin Yaqubie

, Juan Lopez

, Binhui Huang

, Yi-Wei Tang

, Yujia Wen

, Lawrence H. Schwartz

, Anthony B. El-Khoueiry

and 6 other authors

CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Upload

Ghassan K. Abou Alfa, Susan M. Geyer, Andrew B. Nixon

, Federico Innocenti, Qian Shi, Priya Kumthekar, Sawyer Jacobson

, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H. Schwartz, Anthony B. El Khoueiry and 6 other authors

Supplementary Figure 3 from CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Upload

Ghassan K. Abou Alfa, Susan M. Geyer, Andrew B. Nixon

, Federico Innocenti, Qian Shi, Priya Kumthekar, Sawyer Jacobson

, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H. Schwartz, Anthony B. El Khoueiry and 6 other authors

Supplementary Figure 2 from CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Upload

Ghassan K. Abou Alfa, Susan M. Geyer, Andrew B. Nixon

, Federico Innocenti, Qian Shi, Priya Kumthekar, Sawyer Jacobson

, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H. Schwartz, Anthony B. El Khoueiry and 6 other authors

Supplementary Figure 1 from CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Upload

Ghassan K. Abou Alfa, Susan M. Geyer, Andrew B. Nixon

, Federico Innocenti, Qian Shi, Priya Kumthekar, Sawyer Jacobson

, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H. Schwartz, Anthony B. El Khoueiry and 6 other authors

FIGURE 2 from CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Upload

Ghassan K. Abou Alfa, Susan M. Geyer, Andrew B. Nixon

, Federico Innocenti, Qian Shi, Priya Kumthekar, Sawyer Jacobson

, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H. Schwartz, Anthony B. El Khoueiry and 6 other authors

TABLE 2 from CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Upload

Ghassan K. Abou Alfa, Susan M. Geyer, Andrew B. Nixon

, Federico Innocenti, Qian Shi, Priya Kumthekar, Sawyer Jacobson

, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H. Schwartz, Anthony B. El Khoueiry and 6 other authors

TABLE 3 from CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Upload

Ghassan K. Abou Alfa, Susan M. Geyer, Andrew B. Nixon

, Federico Innocenti, Qian Shi, Priya Kumthekar, Sawyer Jacobson

, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H. Schwartz, Anthony B. El Khoueiry and 6 other authors

TABLE 1 from CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Upload

2023 Andrew B. Nixon

, Alexander B. Sibley, Yingmiao Liu, Ace J. Hatch, Chen Jiang, Flora Mulkey, Mark D. Starr, John C. Brady, Donna Niedzwiecki, Alan P. Venook, Luis Baez-Diaz, Heinz-Josef Lenz, Bert H. O'Neil, Federico Innocenti, Jeffrey A. Meyerhardt and 3 other authors

Supplementary Table from Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)

Upload

Andrew B. Nixon

, Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev, Bin Luo, Herbert I. Hurwitz, Phillip G. Febbo, Brian I. Rini, Himisha Beltran, Eric J. Small, Michael J. Morris, Daniel J. George

Data from Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

Upload

Erika J. Lampert, Alexandra Zimmer

, Michelle Padget, Ashley Cimino-Mathews, Jayakumar R. Nair, Yingmiao Liu, Elizabeth M. Swisher, James W. Hodge, Andrew B. Nixon

, Erin Nichols, Mohammad H. Bagheri, Elliott Levy, Marc R. Radke, Stanley Lipkowitz, Christina M. Annunziata and 3 other authors

Data from Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

Upload

Andrew B. Nixon

Data from Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)

Upload

Erika J. Lampert, Alexandra Zimmer

, Michelle Padget, Ashley Cimino-Mathews, Jayakumar R. Nair, Yingmiao Liu, Elizabeth M. Swisher, James W. Hodge, Andrew B. Nixon

, Erin Nichols, Mohammad H. Bagheri, Elliott Levy, Marc R. Radke, Stanley Lipkowitz, Christina M. Annunziata and 3 other authors

Supplementary Data from Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

Upload

Andrew J. Armstrong, Andrew B. Nixon

, Andrea Carmack, Qian Yang, Tim Eisen, Walter M. Stadler, Robert J. Jones, Jorge A. Garcia, Ulka N. Vaishampayan, Joel Picus, Robert E. Hawkins, John D. Hainsworth, Christian K. Kollmannsberger, Theodore F. Logan, Igor Puzanov and 5 other authors

Supplementary Tables and Figures from Angiokines Associated with Targeted Therapy Outcomes in Patients with Non–Clear Cell Renal Cell Carcinoma

Upload

Andrew J. Armstrong, Andrew B. Nixon

Supplementary Figure 4a from Angiokines Associated with Targeted Therapy Outcomes in Patients with Non–Clear Cell Renal Cell Carcinoma

Upload

Andrew B. Nixon

Supplementary Data from Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Andrew Nixon